BioSpace News Archive

Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a biotechnology company developing novel LAG-3 related immunotherapy treatments for cancer and autoimmune disease, is pleased to announce it will report final Overall Survival (OS) data from its Phase IIb AIPAC clinical trial evaluating lead product candidate eftilagimod alpha (“efti” or “IMP321”) in metastatic breast cancer at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2021.

On the morning of September 12, 2021, a complex endovascular intervention was performed at Changhai Hospital of China Naval Medical University by Professor Qing-Sheng Lu’s team using ALLVAS™, China’s first endovascular intervention robot developed by Shanghai Aopeng Medical Technology Co.

Corval LLC today announced the launch of its cloud-based commercialization planning platform designed for early- to mid-stage biopharma companies.

Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye”), announced today its research partner, the University of Mississippi will present late-breaking preclinical data evaluating different nanoemulsion formulations of its prodrug of tetrahydrocannabinol (THC), THCVHS, in addition to the superiority of THCVHS, in lowering intraocular pressure in dutch belted rabbits when co-administered with netarsudil, a rho-kinase inhibitor, at the 2021 American Association of Pharmaceutical Scientists Meeting

Perfusio Corp, a medical device company pioneering real-time visualization of perfusion and blood flow through its Certes™ surgical imaging technology, has captured over 100 patient images in its First-In-person Study into the Perfusio-ARMUS Cloud Repository.

BioSig Technologies, Inc. today announced the appointment of James J. Barry, Ph.D. as an Independent Director to its Board of Directors.

Oryzon Genomics, S.A. announced today that it has received a one million USD grant to support a new clinical trial with our Phase II LSD1 inhibitor vafidemstat in patients with Kabuki syndrome (KS).

Shimadzu Medical Systems USA has announced that the Trinias unity edition product line has been awarded a contract from Vizient, Inc.

Accutar Biotechnology, Inc . today announced that the U.S. Food and Drug Administration (FDA) has cleared the company’s investigational new drug application (IND) for AC0682 for the treatment of patients with estrogen receptor (ER)-positive breast cancers.

The World Health Organization has just featured MediPines AGM100®, pulmonary gas exchange analyzer as an innovative technology in their 2021 compendium, “WHO compendium of innovative health technologies for low-resource settings”.